Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11129856
Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases
granted -
US 11130778
CD73 inhibitors
granted -
US 11124537
Inhibitors of glucocorticoid receptor
granted -
US 11124839
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11124502
Neprilysin inhibitors
granted -
US 11123340
Small-molecule UT-A-selective urea transport inhibitors
granted -
US 11117865
Inhibitors of bromodomain-containing protein 4 (BRD4)
granted -
US 11117900
Compounds useful as inhibitors of ATR kinase
granted -
US 11117888
Irreversible inhibitors of pyruvate kinase M2 and the use thereof
granted -
US 11110108
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted -
US 11110095
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 11110086
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted -
US 11110080
Small molecule inhibitors of bacterial efflux pumps and methods of using same
granted -
US 11110090
Aminopyrimidines as ALK inhibitors
granted -
US 11110103
Inhibitors of glucocorticoid receptor
granted -
US 11110082
Tyrosine kinase inhibitors
granted -
US 11104684
Dimers of covalent NFKB inhibitors
granted -
US 11103491
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 11104660
PDE4D inhibitors
granted -
US 11104730
Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
granted -
US 11098042
Inhibitors of influenza virus replication and uses thereof
granted -
US 11091495
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 11091472
PI-kinase inhibitors with anti-infective activity
granted -
US 11091501
Heterocyclic compounds as RSV inhibitors
granted